Hussein Khaled

5.0k total citations · 1 hit paper
61 papers, 2.7k citations indexed

About

Hussein Khaled is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Hussein Khaled has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 14 papers in Cancer Research. Recurrent topics in Hussein Khaled's work include Colorectal Cancer Screening and Detection (8 papers), Breast Cancer Treatment Studies (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Hussein Khaled is often cited by papers focused on Colorectal Cancer Screening and Detection (8 papers), Breast Cancer Treatment Studies (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Hussein Khaled collaborates with scholars based in Egypt, United States and Malaysia. Hussein Khaled's co-authors include Nabiel Mikhail, Hossam Kamel, Amal Ibrahim, Hoda Baraka, Amr S. Soliman, Ibrahim A. Seifeldin, Clifford A. Hudis, Kathy S. Albain, Kathleen I. Pritchard and Joyce O’Shaughnessy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Annals of Oncology.

In The Last Decade

Hussein Khaled

60 papers receiving 2.6k citations

Hit Papers

Cancer Incidence in Egypt: Results of the National Popula... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hussein Khaled Egypt 23 1.1k 792 628 403 387 61 2.7k
Hannah Yang United States 30 1.1k 1.0× 872 1.1× 476 0.8× 167 0.4× 182 0.5× 84 2.8k
Citadel J. Cabasag France 12 1.0k 1.0× 753 1.0× 519 0.8× 255 0.6× 290 0.7× 22 2.7k
E. Masuyer France 10 1.0k 0.9× 618 0.8× 381 0.6× 184 0.5× 600 1.6× 11 2.6k
Susan L. Kelley United States 17 888 0.8× 1.3k 1.7× 315 0.5× 361 0.9× 290 0.7× 26 3.4k
Alessandro Ottaiano Italy 33 1.7k 1.6× 831 1.0× 468 0.7× 218 0.5× 422 1.1× 194 3.5k
Deborah Mukherji Lebanon 30 1.4k 1.3× 1.2k 1.5× 652 1.0× 263 0.7× 476 1.2× 183 3.4k
Faruk Taş Türkiye 26 1.5k 1.4× 978 1.2× 435 0.7× 204 0.5× 311 0.8× 172 2.9k
Bridget A. Robinson New Zealand 37 2.0k 1.9× 1.3k 1.7× 711 1.1× 615 1.5× 512 1.3× 140 4.4k
Adnan Ghafoor United States 2 1.5k 1.4× 891 1.1× 512 0.8× 297 0.7× 567 1.5× 3 3.2k
Jeffrey S. Chang Taiwan 34 861 0.8× 1.1k 1.3× 533 0.8× 379 0.9× 341 0.9× 79 3.1k

Countries citing papers authored by Hussein Khaled

Since Specialization
Citations

This map shows the geographic impact of Hussein Khaled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hussein Khaled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hussein Khaled more than expected).

Fields of papers citing papers by Hussein Khaled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hussein Khaled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hussein Khaled. The network helps show where Hussein Khaled may publish in the future.

Co-authorship network of co-authors of Hussein Khaled

This figure shows the co-authorship network connecting the top 25 collaborators of Hussein Khaled. A scholar is included among the top collaborators of Hussein Khaled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hussein Khaled. Hussein Khaled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barkana, Buket D., Ahmed El-Sayed, Mark H. Pitcher, et al.. (2022). M-Health System Framework for Diagnosing Inflammatory Breast Cancer with Fuzzy Logic. 93. 1669–1674. 1 indexed citations
2.
Rassy, Elie, Stergios Boussios, Tarek Assi, et al.. (2022). Sarcoma of unknown primary: myth or reality?. Journal of the Egyptian National Cancer Institute. 34(1). 27–27. 3 indexed citations
3.
Shabayek, Marwa I., et al.. (2022). EXOSOMAL CAVEOLIN-1 AS A BIOMARKER OF BLADDER CANCER IN EGYPT. International Journal of Advanced Research. 10(3). 227–235. 1 indexed citations
4.
Zekri, Abdel‐Rahman N., et al.. (2019). Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study. Current Problems in Cancer. 43(6). 100472–100472. 8 indexed citations
5.
Khaled, Hussein, et al.. (2019). The prognostic impact of hypermethylation for a panel of tumor suppressor genes and cell of origin subtype on diffuse large B-cell lymphoma. Molecular Biology Reports. 46(4). 4063–4076. 11 indexed citations
6.
Khaled, Hussein, et al.. (2018). The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017: Egyptian view. Breast Cancer Research and Treatment. 172(3). 545–550. 6 indexed citations
7.
Jaing, Crystal, James B. Thissen, Shea N. Gardner, et al.. (2016). Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncology Letters. 12(4). 2782–2788. 6 indexed citations
8.
Khaled, Hussein, et al.. (2014). Possible Anticancer Activity of Rosuvastatine, Doxazosin, Repaglinide and Oxcarbazepin. Asian Pacific Journal of Cancer Prevention. 15(1). 199–203. 32 indexed citations
9.
Khaled, Hussein. (2013). Schistosomiasis and Cancer in Egypt: Review. Journal of Advanced Research. 4(5). 461–466. 38 indexed citations
10.
Amr, Sania, Doa’a A. Saleh, Laurence S. Magder, et al.. (2013). Pesticides, Gene Polymorphisms, and Bladder Cancer Among Egyptian Agricultural Workers. Archives of Environmental & Occupational Health. 70(1). 19–26. 45 indexed citations
11.
Tohamy, Amany A., et al.. (2013). Role of cyclins A and E in endometrial carcinogenesis in breast cancer patients under tamoxifen treatment. Journal of the Egyptian National Cancer Institute. 25(4). 193–198. 1 indexed citations
12.
Anwar, Waheed, Hussein Khaled, Hassan Amra, Hani El‐Nezami, & Christopher A. Loffredo. (2008). Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: Possibilities for prevention. Mutation Research/Reviews in Mutation Research. 659(1-2). 176–184. 124 indexed citations
13.
Hortobágyi, Gabriel N., Jaime de Salazar, Kathleen I. Pritchard, et al.. (2005). The Global Breast Cancer Burden: Variations in Epidemiology and Survival. Clinical Breast Cancer. 6(5). 391–401. 465 indexed citations
14.
Zekri, Abdel‐Rahman N., et al.. (2005). TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4. Journal of Medical Virology. 75(3). 412–420. 28 indexed citations
15.
Naresh, Kikkeri N., S H Advani, Melissa Adde, et al.. (2004). Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries. Blood Cells Molecules and Diseases. 33(3). 330–337. 36 indexed citations
17.
Zekri, Abdel‐Rahman N., et al.. (2000). Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. Journal of Medical Microbiology. 49(1). 89–95. 44 indexed citations
19.
Khaled, Hussein, et al.. (1996). Combination chemotherapy for advanced bilharzial bladder carcinoma. Annals of Oncology. 7(7). 751–754. 16 indexed citations
20.
Khaled, Hussein, et al.. (1991). A phase II study of epirubicin in breast cancer. Anti-Cancer Drugs. 2(4). 371–374. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026